Sini Thomas
Family · Galveston, TXNPI 1740729847
Payments from drug & device makers
Across 124 payments — averaging $56.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$1K
- Novo Nordisk$977
- Gilead$667
- AbbVie$610
- AstraZeneca$431
- Inspire Medical Systems, Inc.$227
- plus $3K from 26 others
What the payments were for
- Consulting fees$1,20017%
- Travel & lodging$731%
- Food & beverage$5,77382%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 4 | $1,403 |
| Novo Nordisk | 36 | $977 |
| Gilead | 6 | $667 |
| AbbVie | 25 | $610 |
| AstraZeneca | 5 | $431 |
| Inspire Medical Systems, Inc. | 2 | $227 |
| Sanofi | 2 | $218 |
| Abbott | 4 | $198 |
| Bayer | 4 | $191 |
| Madrigal Pharmaceuticals | 1 | $140 |
| Silk Road Medical, Inc. | 1 | $134 |
| Coloplast | 3 | $133 |
| CSL Behring | 1 | $125 |
| Lilly USA, LLC | 1 | $122 |
| Acadia Pharmaceuticals Inc | 1 | $121 |
| Corcept Therapeutics | 1 | $113 |
| Amgen | 2 | $109 |
| EMD Serono, Inc. | 1 | $102 |
| Axsome Therapeutics, Inc. | 1 | $98 |
| Ultragenyx Pharmaceutical Inc. | 1 | $94 |
| Edwards Lifesciences | 1 | $90 |
| SK Life Science, Inc. | 1 | $85 |
| Mylan Specialty L.p. | 1 | $85 |
| Exact Sciences | 6 | $84 |
| Abiomed | 1 | $82 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $81 |
| Jazz Pharmaceuticals Inc. | 1 | $78 |
| Stemline Therapeutics Inc. | 1 | $78 |
| Pfizer | 2 | $61 |
| Boehringer Ingelheim | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Nevro Corp. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,046 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 12 | $467 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $354 |
| Fluticasone Propionate | 14 | $295 |
| Atorvastatin Calcium | 22 | $284 |
| Metformin Hcl | 18 | $185 |
| Losartan Potassium | 15 | $166 |
| Methylprednisolone | 15 | $124 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $114 |
| Lisinopril | 13 | $114 |
| Doxycycline Hyclate | 14 | $106 |
| Azithromycin | 17 | $77 |
| Levothyroxine Sodium | 11 | $75 |
| Meloxicam | 18 | $68 |
| Amlodipine Besylate | 11 | $47 |
| Prednisone | 14 | $18 |
Paid to pharmacies, not to this prescriber.
Other family in Galveston
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.